Potential concerns include: Unknown product quality Contamination or sterility issues Incorrect dosing Injection site reactions Allergic or immune reactions Medication interactions Hormonal or metabolic effects Unclear long-term safety Lack of monitoring Delayed treatment for an actual injury or medical condition Medical oversight is especially important for patients with autoimmune conditions, cancer history, active infections, chronic inflammatory disorders, cardiovascular concerns, hormone-sensitive conditions, or complex medication regimens
Buyers take on the role of regulators, manufacturers, and clinical investigators all at once, with no supporting infrastructure
doi: 10.1007/s00280-018-3561-4 214 DaiXThongchotSDokduangHLoilomeWKhuntikeoNTitapunAet al
Another area of interest is gastrointestinal support
Many patients begin to feel relief within the first 1 to 2 weeks of starting BPC-157 therapy, especially when it is administered near the site of joint pain